These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 34117116)

  • 41. Immune reconstitution and severity of COVID-19 among hematopoietic cell transplant recipients.
    Malek AE; Adachi JA; Mulanovich VE; Sassine J; Raad II; McConn K; Seiler GT; Dhal U; Khawaja F; Chemaly RF
    Transpl Infect Dis; 2021 Aug; 23(4):e13606. PubMed ID: 33755273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic Delays for Non-melanoma Skin Cancers in Renal Transplant Recipients during the COVID-19 Pandemic: What is Hiding Behind the Mask?
    Mokos M; Bašić-Jukić N
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):111-113. PubMed ID: 34477079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical experience of coronavirus disease 2019 in hematopoietic cell transplant and chimeric antigen receptor T-cell recipients.
    Sharma A; Bhatt NS; Hijano DR
    Curr Opin Hematol; 2021 Nov; 28(6):394-400. PubMed ID: 34456224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.
    Elens L; Langman LJ; Hesselink DA; Bergan S; Moes DJAR; Molinaro M; Venkataramanan R; Lemaitre F
    Ther Drug Monit; 2020 Jun; 42(3):360-368. PubMed ID: 32304488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COVID-19 infection in paediatric recipients of allogeneic stem cell transplantation: the UK experience.
    Lucchini G; Furness C; Lawson S; Gibson B; Wynn R; Slatter M; Shillitoe B; James B; Carpenter B; Hough R; Amrolia P; de la Fuente J;
    Br J Haematol; 2021 Aug; 194(4):e74-e77. PubMed ID: 34132400
    [No Abstract]   [Full Text] [Related]  

  • 46. Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9).
    Cesaro S; Ljungman P; Mikulska M; Hirsch HH; von Lilienfeld-Toal M; Cordonnier C; Meylan S; Mehra V; Styczynski J; Marchesi F; Besson C; Baldanti F; Masculano RC; Beutel G; Einsele H; Azoulay E; Maertens J; de la Camara R; ; Pagano L
    Leukemia; 2022 Jun; 36(6):1467-1480. PubMed ID: 35488021
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIV/SARS-CoV-2 coinfection: A global perspective.
    Kanwugu ON; Adadi P
    J Med Virol; 2021 Feb; 93(2):726-732. PubMed ID: 32692406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Managing COVID-19 in Renal Transplant Recipients: A Review of Recent Literature and Case Supporting Corticosteroid-sparing Immunosuppression.
    Johnson KM; Belfer JJ; Peterson GR; Boelkins MR; Dumkow LE
    Pharmacotherapy; 2020 Jun; 40(6):517-524. PubMed ID: 32339304
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Attenuated early inflammatory response in solid organ recipients with COVID-19.
    Bösch F; Börner N; Kemmner S; Lampert C; Jacob S; Koliogiannis D; Stangl M; Michel S; Kneidinger N; Schneider C; Fischereder M; Irlbeck M; Denk G; Werner J; Angele MK; Guba MO
    Clin Transplant; 2020 Oct; 34(10):e14027. PubMed ID: 32589760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SARS-CoV-2 Serologic Immune Response in Exogenously Immunosuppressed Patients.
    Zilla ML; Keetch C; Mitchell G; McBreen J; Shurin MR; Wheeler SE
    J Appl Lab Med; 2021 Mar; 6(2):486-490. PubMed ID: 33367709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A review of the clinical characteristics and management of immunosuppressed patients living with HIV or solid organ transplants infected with SARS-CoV-2 omicron variants.
    Song Y; Lou L; Zhang K
    Front Public Health; 2024; 12():1327093. PubMed ID: 38454994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coronavirus disease 2019 in an orthotopic liver transplant recipient living with human immunodeficiency virus.
    Modi AR; Koval CE; Taege AJ; Modaresi Esfeh J; Eghtesad B; Narayanan Menon KV; Quintini C; Miller C
    Transpl Infect Dis; 2020 Oct; 22(5):e13351. PubMed ID: 32500666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients.
    Colmenero J; Rodríguez-Perálvarez M; Salcedo M; Arias-Milla A; Muñoz-Serrano A; Graus J; Nuño J; Gastaca M; Bustamante-Schneider J; Cachero A; Lladó L; Caballero A; Fernández-Yunquera A; Loinaz C; Fernández I; Fondevila C; Navasa M; Iñarrairaegui M; Castells L; Pascual S; Ramírez P; Vinaixa C; González-Dieguez ML; González-Grande R; Hierro L; Nogueras F; Otero A; Álamo JM; Blanco-Fernández G; Fábrega E; García-Pajares F; Montero JL; Tomé S; De la Rosa G; Pons JA
    J Hepatol; 2021 Jan; 74(1):148-155. PubMed ID: 32750442
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidental COVID-19 in a heart-kidney transplant recipient with malnutrition and recurrent infections: Implications for the SARS-CoV-2 immune response.
    Serrano OK; Kutzler HL; Rochon C; Radojevic JA; Lawlor MT; Hammond JA; Gluck J; Feingold AD; Jaiswal A
    Transpl Infect Dis; 2020 Dec; 22(6):e13367. PubMed ID: 32533615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical characteristics and outcomes of COVID-19 in solid organ transplant recipients: A cohort study.
    Chaudhry ZS; Williams JD; Vahia A; Fadel R; Parraga Acosta T; Prashar R; Shrivastava P; Khoury N; Pinto Corrales J; Williams C; Nagai S; Abouljoud M; Samaniego-Picota M; Abreu-Lanfranco O; Del Busto R; Ramesh MS; Patel A; Alangaden GJ
    Am J Transplant; 2020 Nov; 20(11):3051-3060. PubMed ID: 32654332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclosporine and COVID-19: Risk or favorable?
    Poulsen NN; von Brunn A; Hornum M; Blomberg Jensen M
    Am J Transplant; 2020 Nov; 20(11):2975-2982. PubMed ID: 32777170
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Summary report of seven cases of COVID-19 infection in renal transplant recipients.
    Wang T; Qiu T; Yuan Y; Chen Z; Ma X; Zhang L; Jin Z; Zou J; Zhang Y; Zhou J
    Transpl Immunol; 2021 Dec; 69():101445. PubMed ID: 34384886
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS).
    Haidar G; Agha M; Bilderback A; Lukanski A; Linstrum K; Troyan R; Rothenberger S; McMahon DK; Crandall MD; Sobolewksi MD; Nathan Enick P; Jacobs JL; Collins K; Klamar-Blain C; Macatangay BJC; Parikh UM; Heaps A; Coughenour L; Schwartz MB; Dueker JM; Silveira FP; Keebler ME; Humar A; Luketich JD; Morrell MR; Pilewski JM; McDyer JF; Pappu B; Ferris RL; Marks SM; Mahon J; Mulvey K; Hariharan S; Updike GM; Brock L; Edwards R; Beigi RH; Kip PL; Wells A; Minnier T; Angus DC; Mellors JW
    Clin Infect Dis; 2022 Aug; 75(1):e630-e644. PubMed ID: 35179197
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SARS-CoV-2 vaccine safety and immunogenicity in patients with hematologic malignancies, transplantation, and cellular therapies.
    Ni B; Yanis A; Dee K; Chappell JD; Dulek DE; Kassim AA; Kitko CL; Thomas LD; Halasa N
    Blood Rev; 2022 Nov; 56():100984. PubMed ID: 35752546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.